{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T01:29:01Z","timestamp":1786325341277,"version":"build-2736575974"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004775","name":"Gansu Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["26JRRA366"],"award-info":[{"award-number":["26JRRA366"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009620","name":"Gansu Province Science and Technology Department","doi-asserted-by":"publisher","award":["26JRRA843"],"award-info":[{"award-number":["26JRRA843"]}],"id":[{"id":"10.13039\/501100009620","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.intimp.2026.117141","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T07:21:02Z","timestamp":1784272862000},"page":"117141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mechanisms and research progress of statins in osteoarthritis"],"prefix":"10.1016","volume":"186","author":[{"given":"Haitao","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianxu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannian","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.117141_bb0005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/bmb\/lds038","article-title":"Epidemiology and burden of osteoarthritis","volume":"105","author":"Litwic","year":"2013","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.intimp.2026.117141_bb0010","doi-asserted-by":"crossref","unstructured":"Osteoarthritis, Nat. Rev. Dis. Primers 11(1) (2025) 11.","DOI":"10.1038\/s41572-025-00598-2"},{"issue":"4","key":"10.1016\/j.intimp.2026.117141_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12040923","article-title":"Applications of hydrogels in osteoarthritis treatment","volume":"12","author":"Gan","year":"2024","journal-title":"Biomedicines"},{"issue":"10472","key":"10.1016\/j.intimp.2026.117141_bb0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0140-6736(24)02322-5","article-title":"Osteoarthritis","volume":"405","author":"Kloppenburg","year":"2025","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.intimp.2026.117141_bb0025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41584-020-00533-7","article-title":"Mechanisms and therapeutic implications of cellular senescence in osteoarthritis","volume":"17","author":"Coryell","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117141_bb0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.joca.2014.10.002","article-title":"Metabolic triggered inflammation in osteoarthritis","volume":"23","author":"Wang","year":"2015","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.intimp.2026.117141_bb0035","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.2147\/DDDT.S295224","article-title":"The development of disease-modifying therapies for osteoarthritis (DMOADs): the evidence to date","volume":"15","author":"Oo","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"issue":"11","key":"10.1016\/j.intimp.2026.117141_bb0040","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.joca.2024.07.014","article-title":"Osteoarthritis year in review 2024: epidemiology and therapy","volume":"32","author":"Courties","year":"2024","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.intimp.2026.117141_bb0045","unstructured":"A.B. Bansal, M. Cassagnol, HMG-CoA Reductase Inhibitors, StatPearls, Treasure Island (FL) ineligible companies, Disclosure: Manouchkathe Cassagnol declares no relevant financial relationships with ineligible companies, StatPearls Publishing Copyright \u00a9 2026, StatPearls Publishing LLC, 2026."},{"issue":"4","key":"10.1016\/j.intimp.2026.117141_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25042378","article-title":"Statins-their role in bone tissue metabolism and local applications with different carriers","volume":"25","author":"Granat","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2026.117141_bb0055","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s00204-023-03492-6","article-title":"Understanding the molecular mechanisms of statin pleiotropic effects","volume":"97","author":"German","year":"2023","journal-title":"Arch. Toxicol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117141_bb0060","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.semarthrit.2010.06.010","article-title":"Statins and the joint: multiple targets for a global protection?","volume":"40","author":"Lazzerini","year":"2011","journal-title":"Semin. Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.intimp.2026.117141_bb0065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jbspin.2010.02.035","article-title":"Statins: a potential role in the management of osteoarthritis?","volume":"78","author":"Baker","year":"2011","journal-title":"Joint, Bone, Spine: Revue du Rhumatisme"},{"issue":"16","key":"10.1016\/j.intimp.2026.117141_bb0070","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70791","article-title":"Molecular docking and functional analyses reveal the chondroprotective and anti-inflammatory potential of statins in osteoarthritis","volume":"29","author":"Kilinc","year":"2025","journal-title":"J. Cell. Mol. Med."},{"issue":"4","key":"10.1016\/j.intimp.2026.117141_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0297766","article-title":"Assessing the causal associations of different types of statins use and knee\/hip osteoarthritis: a Mendelian randomization study","volume":"19","author":"Chen","year":"2024","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.intimp.2026.117141_bb0080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41413-021-00147-z","article-title":"Subchondral bone microenvironment in osteoarthritis and pain","volume":"9","author":"Hu","year":"2021","journal-title":"Bone Res."},{"issue":"10182","key":"10.1016\/j.intimp.2026.117141_bb0085","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0140-6736(19)30417-9","article-title":"Osteoarthritis","volume":"393","author":"Hunter","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.intimp.2026.117141_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12010005","article-title":"Osteoarthritis: pathogenesis, animal models, and new regenerative therapies","volume":"12","author":"Szponder","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2026.117141_bb0095","article-title":"Integrating superlubricative nanomaterials with precision drug delivery for advanced osteoarthritis therapy","volume":"35","author":"Gan","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.intimp.2026.117141_bb0100","unstructured":"Global, regional, and national burden of osteoarthritis, 1990\u20132020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021, Lancet Rheumatol. 5(9) (2023) e508\u2013e22."},{"issue":"7","key":"10.1016\/j.intimp.2026.117141_bb0105","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/art.42089","article-title":"Prevalence trends of site-specific osteoarthritis from 1990 to 2019: findings from the Global Burden of Disease Study 2019","volume":"74","author":"Long","year":"2022","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117141_bb0110","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41413-022-00226-9","article-title":"Current understanding of osteoarthritis pathogenesis and relevant new approaches","volume":"10","author":"Tong","year":"2022","journal-title":"Bone Res."},{"issue":"2","key":"10.1016\/j.intimp.2026.117141_bb0115","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.joca.2025.12.013","article-title":"Osteoarthritis year in review 2025: biology","volume":"34","author":"Scerif","year":"2026","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.intimp.2026.117141_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156697","article-title":"Vaccarin ameliorates osteoarthritis by suppressing the c-Jun N-terminal kinase (JNK)-serum amyloid A2 (SAA2) pathway mediating chondrocyte senescence","volume":"141","author":"Gan","year":"2025","journal-title":"Phytomedicine"},{"issue":"10","key":"10.1016\/j.intimp.2026.117141_bb0125","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.joca.2023.06.005","article-title":"Fundamentals of osteoarthritis: inflammatory mediators in osteoarthritis","volume":"31","author":"De Roover","year":"2023","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.intimp.2026.117141_bb0130","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.actbio.2024.05.002","article-title":"Proteolysis of the pericellular matrix: pinpointing the role and involvement of matrix metalloproteinases in early osteoarthritic remodeling","volume":"181","author":"Danalache","year":"2024","journal-title":"Acta Biomater."},{"issue":"10","key":"10.1016\/j.intimp.2026.117141_bb0135","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S1063-4584(03)00150-X","article-title":"The role of reactive oxygen species in homeostasis and degradation of cartilage","volume":"11","author":"Henrotin","year":"2003","journal-title":"Osteoarthr. Cartil."},{"issue":"8","key":"10.1016\/j.intimp.2026.117141_bb0140","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.joca.2005.04.002","article-title":"Oxygen and reactive oxygen species in cartilage degradation: friends or foes?","volume":"13","author":"Henrotin","year":"2005","journal-title":"Osteoarthr. Cartil."},{"issue":"2","key":"10.1016\/j.intimp.2026.117141_bb0145","doi-asserted-by":"crossref","first-page":"C377","DOI":"10.1152\/ajpcell.00464.2022","article-title":"Cartilage extracellular matrix-derived matrikines in osteoarthritis","volume":"324","author":"Rapp","year":"2023","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117141_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041742","article-title":"Overview of MMP-13 as a promising target for the treatment of osteoarthritis","volume":"22","author":"Hu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2026.117141_bb0155","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.joca.2017.02.791","article-title":"ADAMTS and ADAM metalloproteinases in osteoarthritis - looking beyond the \u2018usual suspects\u2019","volume":"25","author":"Yang","year":"2017","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.intimp.2026.117141_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1472613","article-title":"Chondrocyte autophagy mechanism and therapeutic prospects in osteoarthritis","volume":"12","author":"Li","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.intimp.2026.117141_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.625497","article-title":"Chondrocyte aging: the molecular determinants and therapeutic opportunities","volume":"9","author":"Ramasamy","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.intimp.2026.117141_bb0170","article-title":"Subchondral bone remodeling: a therapeutic target for osteoarthritis","volume":"8","author":"Zhu","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117141_bb0175","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s13679-023-00520-5","article-title":"Obesity, metabolic syndrome, and osteoarthritis-an updated review","volume":"12","author":"Sampath","year":"2023","journal-title":"Curr. Obes. Rep."},{"issue":"4","key":"10.1016\/j.intimp.2026.117141_bb0180","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/annrheumdis-2020-218089","article-title":"Microenvironment in subchondral bone: predominant regulator for the treatment of osteoarthritis","volume":"80","author":"Hu","year":"2021","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.intimp.2026.117141_bb0185","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00253-002-0932-9","article-title":"Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs","volume":"58","author":"Manzoni","year":"2002","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117141_bb0190","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13018-025-05487-8","article-title":"The protective effect and experimental research progress of pleotropic statins in intervertebral disc degeneration","volume":"20","author":"Zhang","year":"2025","journal-title":"J. Orthop. Surg. Res."},{"issue":"5","key":"10.1016\/j.intimp.2026.117141_bb0195","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2183\/pjab.86.484","article-title":"A historical perspective on the discovery of statins","volume":"86","author":"Endo","year":"2010","journal-title":"Proc. Jpn. Acad. Ser. B: Phys. Biol. Sci."},{"issue":"6257","key":"10.1016\/j.intimp.2026.117141_bb0200","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.117141_bb0205","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","article-title":"Pleiotropic effects of statins","volume":"45","author":"Liao","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117141_bb0210","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1472-8206.2004.00299.x","article-title":"Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update","volume":"19","author":"Schachter","year":"2005","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"4 Suppl 3","key":"10.1016\/j.intimp.2026.117141_bb0215","article-title":"Pharmacologic characteristics of statins","volume":"26","author":"M","year":"2003","journal-title":"Clin. Cardiol."},{"issue":"6","key":"10.1016\/j.intimp.2026.117141_bb0220","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.clpt.2006.09.003","article-title":"Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance","volume":"80","author":"Neuvonen","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2026.117141_bb0225","article-title":"Effects of statins on sarcopenia with focus on mechanistic insights and future perspectives","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.intimp.2026.117141_bb0230","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00204-008-0344-4","article-title":"Antioxidative effects of statins","volume":"82","author":"Adam","year":"2008","journal-title":"Arch. Toxicol."},{"issue":"6","key":"10.1016\/j.intimp.2026.117141_bb0235","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/art.34453","article-title":"Osteoarthritis: a disease of the joint as an organ","volume":"64","author":"Loeser","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.intimp.2026.117141_bb0240","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nrrheum.2016.136","article-title":"Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis","volume":"12","author":"Robinson","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"issue":"10","key":"10.1016\/j.intimp.2026.117141_bb0245","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0165-6147(02)02077-1","article-title":"Statins as anti-inflammatory agents","volume":"23","author":"Weitz-Schmidt","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2026.117141_bb0250","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10753-017-0516-6","article-title":"Simvastatin inhibits IL-1\u03b2-induced apoptosis and extracellular matrix degradation by suppressing the NF-kB and MAPK pathways in nucleus pulposus cells","volume":"40","author":"Tu","year":"2017","journal-title":"Inflammation"},{"issue":"5","key":"10.1016\/j.intimp.2026.117141_bb0255","first-page":"795","article-title":"Rosuvastatin suppresses TNF-\u03b1-induced matrix catabolism, pyroptosis and senescence via the HMGB1\/NF-\u03baB signaling pathway in nucleus pulposus cells","volume":"55","author":"Chen","year":"2023","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"issue":"20","key":"10.1016\/j.intimp.2026.117141_bb0260","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1080\/15384101.2021.1973707","article-title":"Atorvastatin inhibited TNF-\u03b1 induced matrix degradation in rat nucleus pulposus cells by suppressing NLRP3 inflammasome activity and inducing autophagy through NF-\u03baB signaling","volume":"20","author":"Chen","year":"2021","journal-title":"Cell Cycle"},{"issue":"12","key":"10.1016\/j.intimp.2026.117141_bb0265","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/82219","article-title":"Statins as a newly recognized type of immunomodulator","volume":"6","author":"Kwak","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2026.117141_bb0270","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.phrs.2018.12.010","article-title":"The effects of statin use on inflammatory markers among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials","volume":"141","author":"Tabrizi","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"11","key":"10.1016\/j.intimp.2026.117141_bb0275","article-title":"A systematic review and meta-analysis of the effect of statins on glutathione peroxidase, superoxide dismutase, and catalase","volume":"10","author":"Zinellu","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.intimp.2026.117141_bb0280","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.2147\/JIR.S461348","article-title":"Rosuvastatin: a potential therapeutic agent for inhibition of mechanical pressure-induced intervertebral disc degeneration","volume":"17","author":"Zhang","year":"2024","journal-title":"J. Inflamm. Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.117141_bb0285","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","article-title":"Pleiotropic effects of statins on the cardiovascular system","volume":"120","author":"Oesterle","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.intimp.2026.117141_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116192","article-title":"Advances in the molecular mechanisms of statins in regulating endothelial nitric oxide bioavailability: interlocking biology between eNOS activity and L-arginine metabolism","volume":"171","author":"Chen","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.intimp.2026.117141_bb0295","first-page":"567","article-title":"The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation","volume":"3","author":"Gelosa","year":"2007","journal-title":"Vasc. Health Risk Manag."},{"issue":"6","key":"10.1016\/j.intimp.2026.117141_bb0300","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1042\/BSR20110118","article-title":"Mechanisms of bone anabolism regulated by statins","volume":"32","author":"Ruan","year":"2012","journal-title":"Biosci. Rep."},{"issue":"2","key":"10.1016\/j.intimp.2026.117141_bb0305","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/bbrc.2001.5597","article-title":"Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts","volume":"287","author":"Ohnaka","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.intimp.2026.117141_bb0310","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ajodo.2016.08.026","article-title":"Atorvastatin-induced osteoclast inhibition reduces orthodontic relapse","volume":"151","author":"Dolci","year":"2017","journal-title":"Am. J. Orthod. Dentofacial Orthop."},{"key":"10.1016\/j.intimp.2026.117141_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117805","article-title":"Statins and non-alcoholic fatty liver disease: a concise review","volume":"183","author":"da Silva Pereira","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.intimp.2026.117141_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9010022","article-title":"Statin-related myotoxicity: a comprehensive review of pharmacokinetic, pharmacogenomic and muscle components","volume":"9","author":"Turner","year":"2019","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117141_bb0325","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12935-023-02890-1","article-title":"Paradoxical effects of statins on endothelial and cancer cells: the impact of concentrations","volume":"23","author":"Ahmadi","year":"2023","journal-title":"Cancer Cell Int."},{"issue":"1\u20133","key":"10.1016\/j.intimp.2026.117141_bb0330","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejphar.2011.10.022","article-title":"Comparative effects of high and low-dose simvastatin on prostate epithelial cells: the role of LDL","volume":"673","author":"Murtola","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117141_bb0335","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.joca.2008.06.012","article-title":"Mevastatin reduces cartilage degradation in rabbit experimental osteoarthritis through inhibition of synovial inflammation","volume":"17","author":"Akasaki","year":"2009","journal-title":"Osteoarthr. Cartil."},{"issue":"1","key":"10.1016\/j.intimp.2026.117141_bb0340","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrrheum.2013.159","article-title":"Progress in intra-articular therapy","volume":"10","author":"Evans","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"issue":"12","key":"10.1016\/j.intimp.2026.117141_bb0345","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41584-020-00518-6","article-title":"Emerging pharmaceutical therapies for osteoarthritis","volume":"16","author":"Latourte","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117141_bb0350","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41584-022-00749-9","article-title":"Synovial inflammation in osteoarthritis progression","volume":"18","author":"Sanchez-Lopez","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117141_bb0355","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cardiores.2007.06.003","article-title":"Mechanism of TNFalpha-induced IL-1alpha, IL-1beta and IL-6 expression in human cardiac fibroblasts: effects of statins and thiazolidinediones","volume":"76","author":"Turner","year":"2007","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.117141_bb0360","doi-asserted-by":"crossref","first-page":"19237","DOI":"10.1038\/s41598-025-02418-9","article-title":"Anti-inflammatory effect of fluvastatin on polarized macrophages and its dependence on the mevalonate pathway","volume":"15","author":"Muffova","year":"2025","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.intimp.2026.117141_bb0365","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/ard.2003.009746","article-title":"Simvastatin reduces MMP-3 level in interleukin 1beta stimulated human chondrocyte culture","volume":"63","author":"Lazzerini","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2026.117141_bb0370","article-title":"The Immunological Facets Of Chondrocytes In Osteoarthritis: A Narrative Review","author":"Sengprasert","year":"2023","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.intimp.2026.117141_bb0375","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.intimp.2018.09.018","article-title":"Pravastatin alleviates interleukin 1\u03b2-induced cartilage degradation by restoring impaired autophagy associated with MAPK pathway inhibition","volume":"64","author":"Mao","year":"2018","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117141_bb0380","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11051313","article-title":"Antioxidant effects of statins by modulating Nrf2 and Nrf2\/HO-1 signaling in different diseases","volume":"11","author":"Mansouri","year":"2022","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.intimp.2026.117141_bb0385","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bbrc.2010.04.117","article-title":"Simvastatin lowers reactive oxygen species level by Nrf2 activation via PI3K\/Akt pathway","volume":"396","author":"Chartoumpekis","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.intimp.2026.117141_bb0390","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s40265-021-01510-4","article-title":"Targeting AMPK by statins: a potential therapeutic approach","volume":"81","author":"Dehnavi","year":"2021","journal-title":"Drugs"},{"issue":"24","key":"10.1016\/j.intimp.2026.117141_bb0395","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1161\/CIRCULATIONAHA.106.630194","article-title":"Statins activate AMP-activated protein kinase in vitro and in vivo","volume":"114","author":"Sun","year":"2006","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.intimp.2026.117141_bb0400","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10071477","article-title":"The role of mitochondrial metabolism, AMPK-SIRT mediated pathway, LncRNA and microRNA in osteoarthritis","volume":"10","author":"Liu","year":"2022","journal-title":"Biomedicines"},{"issue":"3\u20134","key":"10.1016\/j.intimp.2026.117141_bb0405","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00011-014-0794-5","article-title":"Anti-inflammatory and chondroprotective effects of atorvastatin in a cartilage explant model of osteoarthritis","volume":"64","author":"Pathak","year":"2015","journal-title":"Inflamm. Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.117141_bb0410","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/jor.20953","article-title":"Protective effect of atorvastatin in cultured osteoarthritic chondrocytes","volume":"28","author":"Simopoulou","year":"2010","journal-title":"J. Orthop. Res."},{"issue":"2","key":"10.1016\/j.intimp.2026.117141_bb0415","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11684-024-1061-y","article-title":"Pathological progression of osteoarthritis: a perspective on subchondral bone","volume":"18","author":"Li","year":"2024","journal-title":"Front. Med."},{"issue":"3","key":"10.1016\/j.intimp.2026.117141_bb0420","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s43440-025-00716-7","article-title":"Molecular mechanisms underlying the effects of statins on bone metabolism: an evolving paradigm of statins delivery modalities for bone regeneration","volume":"77","author":"Zaki","year":"2025","journal-title":"Pharmacol. Rep."},{"issue":"21 Suppl 1","key":"10.1016\/j.intimp.2026.117141_bb0425","article-title":"Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress","volume":"109","author":"Mason","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.intimp.2026.117141_bb0430","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s13018-020-01841-0","article-title":"Atorvastatin promotes bone formation in aged apoE(-\/-) mice through the Sirt1-Runx2 axis","volume":"15","author":"Hong","year":"2020","journal-title":"J. Orthop. Surg. Res."},{"issue":"17","key":"10.1016\/j.intimp.2026.117141_bb0435","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179208","article-title":"Cytokines and chemokines involved in osteoarthritis pathogenesis","volume":"22","author":"Molnar","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.117141_bb0440","article-title":"The damage-associated molecular patterns (DAMPs) as potential targets to treat osteoarthritis: perspectives from a review of the literature","volume":"7","author":"Lambert","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"issue":"12","key":"10.1016\/j.intimp.2026.117141_bb0445","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8122051","article-title":"Statin-induced nitric oxide signaling: mechanisms and therapeutic implications","volume":"8","author":"Gorabi","year":"2019","journal-title":"J. Clin. Med."},{"issue":"12","key":"10.1016\/j.intimp.2026.117141_bb0450","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nrd1901","article-title":"Anti-inflammatory effects of statins: clinical evidence and basic mechanisms","volume":"4","author":"Jain","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.intimp.2026.117141_bb0455","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11883-025-01342-7","article-title":"Beyond LDL cholesterol reduction: pleiotropic profiling of statins","volume":"27","author":"Ayyalu","year":"2025","journal-title":"Curr. Atheroscler. Rep."},{"issue":"4","key":"10.1016\/j.intimp.2026.117141_bb0460","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.174125","article-title":"High-dose atorvastatin therapy progressively decreases skeletal muscle mitochondrial respiratory capacity in humans","volume":"9","author":"Ryan","year":"2024","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.intimp.2026.117141_bb0465","first-page":"463","article-title":"Simvastatin inhibits production of interleukin 6 (IL-6) and IL-8 and cell proliferation induced by tumor necrosis factor-alpha in fibroblast-like synoviocytes from patients with rheumatoid arthritis","volume":"33","author":"Yokota","year":"2006","journal-title":"J. Rheumatol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117141_bb0470","first-page":"696","article-title":"Simvastatin inhibits cytokine production and nuclear factor-kB activation in interleukin 1beta-stimulated synoviocytes from rheumatoid arthritis patients","volume":"25","author":"Lazzerini","year":"2007","journal-title":"Clin. Exp. Rheumatol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117141_bb0475","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/03009740802572475","article-title":"Anti-inflammatory effects of atorvastatin on peripheral blood mononuclear cells and synovial fibroblasts in rheumatoid arthritis","volume":"38","author":"Blaschke","year":"2009","journal-title":"Scand. J. Rheumatol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117141_bb0480","first-page":"193","article-title":"High concentration simvastatin induces apoptosis in fibroblast-like synoviocytes from patients with rheumatoid arthritis","volume":"35","author":"Yokota","year":"2008","journal-title":"J. Rheumatol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117141_bb0485","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/s10165-009-0183-z","article-title":"Geranylgeranylacetone, a non-toxic inducer of heat shock protein, induces cell death in fibroblast-like synoviocytes from patients with rheumatoid arthritis","volume":"19","author":"Nanke","year":"2009","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.intimp.2026.117141_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2024.105806","article-title":"Lovastatin impairs cellular proliferation and enhances hyaluronic acid production in fibroblast-like synoviocytes","volume":"97","author":"Wu","year":"2024","journal-title":"Toxicol. in Vitro"},{"issue":"4","key":"10.1016\/j.intimp.2026.117141_bb0495","doi-asserted-by":"crossref","first-page":"R94","DOI":"10.1186\/ar1968","article-title":"Inhibition of protein geranylgeranylation induces apoptosis in synovial fibroblasts","volume":"8","author":"Connor","year":"2006","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.intimp.2026.117141_bb0500","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejphar.2005.05.005","article-title":"Anti-inflammatory and analgesic effects of atorvastatin in a rat model of adjuvant-induced arthritis","volume":"516","author":"Barsante","year":"2005","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117141_bb0505","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.phrs.2009.11.006","article-title":"Atorvastatin ameliorates inflammatory hyperalgesia in rat model of monoarticular arthritis","volume":"61","author":"Wahane","year":"2010","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.intimp.2026.117141_bb0510","first-page":"534","article-title":"Influence of simvastatin on the production of pro-inflammatory cytokines and nitric oxide by activated human chondrocytes","volume":"25","author":"Dombrecht","year":"2007","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117141_bb0515","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.4049\/jimmunol.170.3.1524","article-title":"A novel anti-inflammatory role for simvastatin in inflammatory arthritis","volume":"170","author":"Leung","year":"2003","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2026.117141_bb0520","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1002\/art.20673","article-title":"Assessment of the efficacy of different statins in murine collagen-induced arthritis","volume":"50","author":"Palmer","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.intimp.2026.117141_bb0525","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00296-006-0270-9","article-title":"Effects of pravastatin in murine collagen-induced arthritis","volume":"27","author":"Yamagata","year":"2007","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.intimp.2026.117141_bb0530","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2024.1390387","article-title":"Exploring the causal link among statin drugs and the osteoarthritis risk based on Mendelian randomization research","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Genet."},{"issue":"5","key":"10.1016\/j.intimp.2026.117141_bb0535","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1007\/s11096-024-01754-6","article-title":"Causal impact of statins on susceptibility to osteoarthritis: insights from a two-sample Mendelian randomization analysis","volume":"46","author":"Yu","year":"2024","journal-title":"Int. J. Clin. Pharm."},{"issue":"9426","key":"10.1016\/j.intimp.2026.117141_bb0540","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(04)16449-0","article-title":"Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial","volume":"363","author":"McCarey","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.intimp.2026.117141_bb0545","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1211\/jpp.58.1.0002","article-title":"Statins and osteoporosis: new role for old drugs","volume":"58","author":"Jadhav","year":"2006","journal-title":"J. Pharm. Pharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926009872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926009872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:45:34Z","timestamp":1786322734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926009872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":109,"alternative-id":["S1567576926009872"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117141","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms and research progress of statins in osteoarthritis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117141","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117141"}}